Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Tonix Pharmaceuticals Holding Corp.
About TNXP
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and vaccines to prevent, disease and alleviate suffering. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801, TNX-1800, TNX-4200, and TNX-1700. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.
Find out what a historical investment in Tonix Pharmaceuticals Holding Corp. would be worth today using our TNXP stock calculator.
Market Capitalisation
$218.55M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
221.74K
High today
$14.71
Low today
$13.70
Open price
$13.80
52-week high
$69.97
52-week low
$11.60
Ready to start your investing journey with Stake?
Open an accountHow do I buy TNXP shares in Australia?
Buying TNXP shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Tonix Pharmaceuticals Holding Corp. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in TNXP
What is the ticker symbol of Tonix Pharmaceuticals Holding Corp.?
The ticker symbol for Tonix Pharmaceuticals Holding Corp. is TNXP.
How much is one share of TNXP?
One share of TNXP is valued at $14.49 as of 20 May 2026.
What is the market capitalisation of Tonix Pharmaceuticals Holding Corp. TNXP?
As of 20 May 2026 Tonix Pharmaceuticals Holding Corp. has a market cap of $218.55M.
What is the 52-week high for Tonix Pharmaceuticals Holding Corp. stock?
The Tonix Pharmaceuticals Holding Corp. 52-week high stock price is $69.97.
What is the 52-week low for Tonix Pharmaceuticals Holding Corp. stock?
The Tonix Pharmaceuticals Holding Corp. 52-week low stock price is $11.60.
Can I buy TNXP shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy TNXP shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in TNXP on Stake
- Buy TNXP from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of TNXP from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
TNXP related stocks